We are live on
!
Find out more
LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $5.77M | – | – | – |
|
2
Macquarie Group
Sydney, NSW 2000,
Australia
| $57K | +$57.5K | +14,718 | New |
|
3
Geode Capital Management
Boston,
Massachusetts
| $48.8K | +$49.2K | +12,604 | New |
|
4
Renaissance Technologies
New York
| $40K | +$40.1K | +10,260 | New |
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | +$2.33K | +597 | +98% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $4.58K | -$1.41K | -362 | -23% |
|
7
JP Morgan Chase
New York
| $228 | – | – | – |
|
8
BlackRock
New York
| $163 | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $144 | – | – | – |
|
10
Wells Fargo
San Francisco,
California
| $35 | – | – | – |
|